The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
2010

Eisenmenger Syndrome: Management and Treatment Update

publication Evidence: moderate

Author Information

Author(s): Oechslin Erwin, Mebus Siegrun, Schulze-Neick Ingram, Niwa Koichiro, Trindade Pedro T, Eicken Andreas, Hager Alfred, Lang Irene, Hess John, Kaemmerer Harald

Primary Institution: Congenital Cardiac Centre for Adults, University Health Network/Toronto General Hospital/Peter Munk Cardiac Centre

Hypothesis

Can new treatments improve the quality of life for patients with Eisenmenger syndrome?

Conclusion

Referral to specialized centers and targeted medical treatments can optimize outcomes for Eisenmenger patients.

Supporting Evidence

  • Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension.
  • New selective pulmonary vasodilators have shown benefits in various forms of pulmonary arterial hypertension.
  • Referral to specialized centers is crucial for optimizing patient outcomes.

Takeaway

Eisenmenger syndrome is a serious heart condition that can be managed better with specialized care and new treatments.

Methodology

The article reviews current diagnostic and therapeutic options for Eisenmenger patients, focusing on management and surgical aspects.

Limitations

Data on Eisenmenger patients often suffer from small sample sizes and lack of randomized controlled studies.

Digital Object Identifier (DOI)

10.2174/157340310793566127

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication